ImmuPharma PLC (AIM:IMM) said it had noted the Incanthera PLC (AQSE:INC) announcement of the launch of its Skin + CELL skincare range with Marionnaud Switzerland and Austria, part of the A.S. Watson Group, and its £1 million fundraiser. ImmuPharma owns 12.7% of Incanthera.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com